ArticleJournal of cancer research and clinical oncology2014

Abundant in vitro expression of the oncofetal ED-B-containing fibronectin translates into selective pharmacodelivery of (131)I-L19SIP in a prostate cancer patient.

Ricarda Locher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.